WHAT REALLY HAPPENS WHEN YOU TAKE OZEMPIC, WEGOVY, MOUNJARO, OR ZEPBOUND FOR YEARS?
A personal GLP-1 medical journey, documented blood tests, and an investigation into weight loss, metabolism, muscle, the brain, side effects, and life after treatment.
From the author of UNSUGAR, Rextosterone, and The Sober Brain Reset comes a firsthand account of GLP-1 treatment backed by medical records and extensive scientific research.
Pop Buchanan did not begin GLP-1 treatment simply to lose weight.
Living with multiple chemical sensitivity, hyperosmia, hyperthyroidism, and other health challenges, he and his doctors were working to improve his metabolic and hormonal health as part of a broader medical plan. They were also investigating possible contributors to his disabling symptoms.
GLP-1 medication became one part of that plan. Over the following years, Buchanan's reported weight fell from approximately 245 to 196 pounds. His medical records document A1C readings of 5.6% and 5.4%, along with glucose, kidney-function, and cholesterol measurements. He shares what changed, what he experienced, and what the records can and cannot prove.
His experience inspired a larger investigation: What happens inside the body during GLP-1 treatment? How much weight lost is fat or lean tissue? Why do some people struggle with side effects? What happens when treatment ends?
THE SCIENCE BEHIND THE WEIGHT LOSS
Understand how semaglutide and tirzepatide influence hunger, fullness, digestion, insulin, blood sugar, and metabolism. Explore food noise, weight-loss plateaus, and head-to-head findings comparing these medications, including Ozempic, Wegovy, Mounjaro, and Zepbound.
Examine research on benefits beyond weight loss, including cardiovascular health, kidney disease, sleep apnea, and metabolic liver disease.
SIDE EFFECTS, SAFETY, AND MUSCLE HEALTH
Learn about nausea, vomiting, constipation, diarrhea, gastroparesis, gallstones, pancreatitis, dehydration, kidney injury, thyroid warnings, vision complications, and precautions before anesthesia.
Discover why muscle loss, protein intake, nutrition, resistance exercise, and strength matter during substantial weight reduction.
THE BRAIN, CRAVINGS, AND SEXUAL HEALTH
Explore emerging research on dopamine, appetite, alcohol cravings, addiction, libido, erectile dysfunction, and testosterone. Understand how misleading headlines and counterfeit medications can distort treatment decisions.
WHAT HAPPENS WHEN YOU STOP?
See what clinical trials reveal about returning appetite, weight regain, and long-term treatment decisions after semaglutide or tirzepatide withdrawal.
A PERSONAL JOURNEY. DOCUMENTED RESULTS. A SCIENTIFIC INVESTIGATION.
Buchanan brings together firsthand experience, physician-supervised care, dated laboratory findings, clinical trials, and FDA warnings. His personal outcomes are presented transparently, without claiming that GLP-1 medication alone caused every improvement or treated his underlying disability.
Whether you're considering treatment, already taking a GLP-1 medication, managing side effects, or planning for what comes next, The GLP-1 Trade-Off helps you understand the benefits, risks, and decisions beyond the scale.
Know the benefits. Understand the risks. Plan beyond the prescription.
